Adagio Medical Holdings, Inc. (ADGM) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Adagio Medical Holdings, Inc. in 2026. The next earnings report is expected on November 12, 2026.
Next earnings date
12 Nov 2026
In 83 days
EPS estimate
-0.25
Revenue estimate
0
Past earnings
Latest earnings analysis
Adagio Medical Holdings, Inc. missed consensus estimates in its latest earnings report, with EPS of -$0.30 versus an estimate of -$0.27, while revenue of $0 matched expectations. In the prior quarter EPS also missed estimates and revenue likewise met expectations.
No dividend history available.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Adagio Medical Holdings, Inc. (ADGM) is scheduled to report earnings on November 12, 2026.
Adagio Medical Holdings, Inc. (ADGM) last reported earnings on August 11, 2026.
Adagio Medical Holdings, Inc. (ADGM) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.